Molecular analysis of individual tumor tissue is necessary to develop tomorrow’s personalized cancer medicines. Our team is supporting the international biopharmaceutical industry since 2005 with high quality biomarker analysis in clinical trials and helped to bring many innovative therapies to the patient. Discovery Life Sciences has grown into a global leader in the fields of development and application of predictive biomarkers and tissue research. Our employees are the strength of our company. The entire team works with dedication to maintain and expand our leading position for the benefit of patients.